 "Pharma, IT needn’t be good contra calls")
There are only two sectors, pharmaceuticals and information technology (IT), which have disappointed investors in the past year. In a year when the National Stock Exchange’s Nifty 50 is up 17.2 per cent, and all sectoral indices have given positive returns, pharma and IT sectoral indices, which have declined with 11.3 per cent and 10.6 per cent, respectively, stand out like sore thumbs.
While pharma and IT mutual fund schemes have done better by falling much less, that is, -3.68 per cent (pharma) and -5.11 per cent (IT), it is still disappointing for investors who are seeing a bull
While pharma and IT mutual fund schemes have done better by falling much less, that is, -3.68 per cent (pharma) and -5.11 per cent (IT), it is still disappointing for investors who are seeing a bull
